ArticlePediatric research2026
Hyperbilirubinemia and phototherapy differentially alter hippocampal transcriptome in the preterm Gunn rat model.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundPreterm infants are at risk for bilirubin-induced brain injury. Phototherapy is effective for lowering serum bilirubin but has potential adverse effects. The independent effects of hyperbilirubinemia and phototherapy on the hippocampal gene expression profile were determined using a preterm-equivalent Gunn rat model.
methodsJaundiced and non-jaundiced pups were subjected to phototherapy from postnatal day (P) 4 through P6. Hippocampal transcriptome was assessed on P6 using genome-wide RNA sequencing (RNAseq) followed by qPCR validation of top 5 upregulated and 5 downregulated (>1.8- absolute fold change) genes.
resultsPhototherapy lowered serum bilirubin in jaundiced pups on P6, compared with untreated pups (5.37 ± 0.54 mg/dL vs. 8.83 ± 0.55 mg/dL, p < 0.0001). RNAseq identified 1294 differentially expressed genes (DEG) for hyperbilirubinemia, 3297 DEGs for phototherapy, with 407 overlap DEGs. qPCR confirmed the expression of all top upregulated and downregulated genes affected by phototherapy (Ano3, Gabarapl2, Myo16, Vsnl1, Arhgef9, Rnfl6, Xpo5, Mcm3, Draxin) except Dnmt1.
conclusionBoth hyperbilirubinemia and phototherapy altered the transcriptome of the developing rat hippocampus with phototherapy having a 2.5-fold greater impact than hyperbilirubinemia. The top transcripts identified indicate that phototherapy impacts important CNS functions including neurogenesis, synaptogenesis, and microtubule dynamics. IMPACT: This study utilized a model of phototherapy treatment in a preterm Gunn rat model of hyperbilirubinemia. Data demonstrate that mild hyperbilirubinemia, and to an even greater extent, phototherapy, induces widespread gene expression changes in the developing hippocampus. Phototherapy was associated with differentially expressed genes related to neurogenesis, synaptogenesis, and microtubule dynamics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.